Strategic pillars for sustainable growth;

The dynamics of our industry requires us to be relentlessly alert and able to take full advantage of the ongoing opportunities generated by the evolving biopharmaceutical science. Therefore, we systematically monitor scientific progress seeking for new products, partnerships and markets.

Furthermore, in today’s business environment, achieving high performance and competitiveness requires strong commitment to quality and excellence.

Guided by these principles, we carefully plan our steps, on a course of continuous, dynamic and sustainable growth.

We are building our development expertise in collaboration with industry leaders Key elements of our strategy include:

Developing and broadening our core franchises in Generic injectable therapeutic hospital focused pharmaceuticals.

Continuing to build our platform by entering into new partnerships and advancing our currently-partnered programs.

We have active partnerships across a diverse range of therapeutic areas and geographies. Our partners include global pharmaceutical companies. We will continue to consider entering additional collaborations with partners that want to combine their disease and target know-how with our ability to build market share and enter new territories.